TOTAL LUNG CAPACITY INCREASED

#	Drug	Count
0	PREDNISONE	128
1	ALBUTEROL SULFATE	97
2	MEPOLIZUMAB	93
3	TIOTROPIUM BROMIDE	92
4	MONTELUKAST SODIUM	84
5	IPRATROPIUM BROMIDE	82
6	CICLESONIDE	78
7	CIPROFLOXACIN HYDROCHLORIDE	76
8	FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE	72
9	MOMETASONE FUROATE	72

#	Drug	Count	Frequency
0	TIPRANAVIR	42	0.0353
1	ENFUVIRTIDE	42	0.0126
2	ACLIDINIUM BROMIDE	55	0.0099
3	GLYCOPYRROLATE	47	0.0080
4	CICLESONIDE	78	0.0076
5	MOXIFLOXACIN HYDROCHLORIDE	69	0.0056
6	ABACAVIR SULFATE	42	0.0050
7	BISCODYL	40	0.0041
8	BISACODYL	40	0.0037
9	MEPOLIZUMAB	93	0.0034

#	Drug class	Count
0	Corticosteroid [EPC]	136
1	Interleukin-5 Antagonist [EPC]	93
2	Anti-IgE [EPC]	67
3	Benzodiazepine [EPC]	43
4	Cytochrome P450 3A Inhibitor [EPC]	43
5	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	43
6	Protease Inhibitor [EPC]	43
7	Atypical Antipsychotic [EPC]	42
8	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	42
9	Mood Stabilizer [EPC]	42

#	Drug class	Count	Frequency
0	Stimulant Laxative [EPC]	40	0.0037
1	Interleukin-5 Antagonist [EPC]	93	0.0033
2	Anti-IgE [EPC]	67	0.0012
3	Polyene Antifungal [EPC]	41	0.0012
4	Protease Inhibitor [EPC]	43	0.0010
5	Antimalarial [EPC]	6	0.0009
6	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	42	0.0009
7	Cytochrome P450 3A Inhibitor [EPC]	43	0.0008
8	Antiprotozoal [EPC]	6	0.0007
9	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]	43	0.0004